Status:

UNKNOWN

Erector Spinae Plane Block With Ropivacaine for Major Upper Abdominal Surgery

Lead Sponsor:

Nazarbayev University Medical Center

Collaborating Sponsors:

National Research Oncology and Transplantology Center, Kazakhstan

Conditions:

Pain, Postoperative

Eligibility:

All Genders

18-70 years

Phase:

PHASE3

Brief Summary

Prospective, single-centre, randomized, controlled, open-label, evaluator-blinded, superiority trial.

Detailed Description

The primary objective is to establish whether ESP ropivacaine reduces post-operative opioid use and improves pain rating post-operatively. The secondary objectives include adverse event incidence, tim...

Eligibility Criteria

Inclusion

  • Adults who are scheduled to undergo major upper abdominal surgery (e.g. Pancreato-duodenal resection). If enrollment rates are insufficient, patients undergoing other major upper abdominal surgery will be enrolled (e.g in the supraumbilical area: liver resection, colon resection; Whipple procedure; gastrectomy).
  • Males or females 18-70 years of age
  • American Society of Anesthesiologists physical status class I,II, III
  • Signed informed consent

Exclusion

  • Patients undergoing emergency surgery
  • Decompensated cardiovascular disease (e.g. left ventricular ejection fraction ≤40%), chronic heart failure, rhythm and conduction disorders, coagulopathies)
  • Comorbid obesity (BMI≥35kg/m2)
  • Anomalies of vertebral column
  • Use of anticoagulants and patients with hypocoagulable conditions
  • Pregnancy
  • Physician preference for therapeutic anticoagulation
  • Infection of skin at site of needle puncture
  • Known allergies to study drugs

Key Trial Info

Start Date :

January 1 2021

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

August 1 2021

Estimated Enrollment :

50 Patients enrolled

Trial Details

Trial ID

NCT04702685

Start Date

January 1 2021

End Date

August 1 2021

Last Update

January 11 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

National Center for Oncology

Astana, Kazakhstan